Українська English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)
DOI: https://doi.org/10.15407/fz

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2015; 61(5): 11-20

Proteasomal activity in brain tissue following ischemic stroke in Wistar rats

O.I. Savchuk1, M.O. Orlovsky1, Ie.S. Iarmoliuk2, S.V. Goncharov1, V.E. Dosenko1, G.G. Skibo1

  1. О.О. Bogomoletz Institute of Physiology of National Academy of Science of Ukraine, Kyiv, Ukraine
  2. О.О. Bogomolets National Medical University, Kyiv, Ukraine
DOI: https://doi.org/10.15407/fz61.05.011


Abstract

Functional as well as structural reorganization of brain tissues takes place in the surrounding and remotes brain areas after focal ischemic lesions. In particular, reactive or regenerative processes have been described to occur in the infarction areas and the contralateral hemisphere. Experiments were performed on 63 rats, divided into 3 groups (each consisted of 21 animals): sham operated, short-term occlusion of the right middle cerebral artery (MCAO) group, and long-term MCAO group. We have studied changes in proteasome proteolysis during transient occlusion of the middle cerebral artery using method of Koizumi J., duration 2 and 60 min and made the comparison between changes in different types of proteasome activity and severity of ischemic injury and showed three types of decrease in proteolytic activity (trypsin-, chymotrypsin-like, peptidylglutamyl peptide-hydrolyzing) in the brain tissues. Chymotrypsin-like activity of ischemic areas of the brain for short-term MCAO decreased 4.1 times compared with controls (P>0.05), for long-term MCAO decreased 5.8 times compared with controls (P<0.05). Trypsin-like activity of ischemic areas of brain for short-term MCAO decreased 7.1 times compared with controls (P>0.05), for long-term MCAO decreased 12.5 times compared with controls (P<0.05). PGPH activity of ischemic areas for shortterm MCAO decreased 8 times compared with controls (P>0.05), for long-term MCAO decreased 2.8 times compared with controls (P<0.05). The similar dynamics was observed also in the penumbra and the core zone of the brain at 6 h of reperfusion, in the long run there is no significant difference between the core and contralateral zones. Our results suggest that proteasome activity may play also a role in contralateral cortical plasticity occurring after focal cerebral ischemia.

Keywords: ischemic stroke; focal cerebral ischemia; proteasome

Full text: (PDF, in English)

References

    Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB. Heart disease and stroke statistics–2012 update: a report from the American Heart Association. Circulation. 2012;125:2-220 CrossRef PubMed PubMedCentral  
  1. Britton P, Lu X-C, Laskosky M, Tortella FC. Dextromethorphan protects against cerebral injury following transient, but not permanent, focal ischemia in rats. Life Sci. 1997;60:1729-40. CrossRef  
  2. Bulteau AL, Lundberg KC, Humphries KM. Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion. 2001;276:30057–63.
    3.  
  3. Phillips JB, Williams AJ, Adams J, Elliott PJ, Tortella FC. Proteasome inhibitor PS519 reduces infarction and attenuates leukocyte infiltration in a rat model of focal cerebral ischemia. Stroke. 2000;31:1686–93. CrossRef PubMed
    4.  
  4. Moskowitz MA, Lo EH, Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron. 2010;67:181–98. CrossRef PubMed PubMedCentral
    5.  
  5. Ge P, Luo Y, Liu CL, Hu B. Protein aggregation and proteasome dysfunction after brain ischemia. Stroke. 2007;38:3230–6. CrossRef PubMed PubMedCentral
    6.  
  6. Ross CA, Poirier MA. Protein aggregation and neurodegenerative disease. Nat Med 2004;10:10–17. CrossRef PubMed
    7.  
  7. Orlowski M, Wilk S. Catalytic activities of the 20 S proteasome, a multicatalytic proteinase complex. Arch Biochem Biophys. 2000;383:1–16. CrossRef PubMed
    8.  
  8. Ross CA, Poirier MA. Opinion: What is the role of protein aggregation in neurodegeneration? Mol. Cell Biol. 2005;6:891–8.
    9.  
  9. Phillips JB, Williams AJ, Adams J, Elliott PJ, Tortella FC. Proteasome inhibitor PS519 reduces infarction and attenuates leukocyte infiltration in a rat model of focal cerebral ischemia. Stroke. 2000;31:1686–93. CrossRef PubMed
    10.  
  10. Koizumi J, Yoshida Y, Nakazawa T, Ooneda G. Experimental studies of ischcmic brain edema. A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Stroke. 1986;8:l-8.
    11.  
  11. Iarmoliuk IeS. Dynamics of functional disorders in different variants of tissue transplantation to activate angiogenesis on the models of focal cerebral ischemia in rats. Ukr NMM Zh. 2014; 82(3):123-8. [Ukrainian].
    12.  
  12. Dosenko VE, Zagoriĭ VIu, Moĭbenko AA. Effect of proteasomal proteolysis on NO-synthase activity in isolated platelets. Ukr Biokhim Zh. 2005; 77:39–43.
    13.  
  13. Pashevin DO, Dosenko VE, Byts IuV, Moibenko OO: Proteasome activity changes in the aorta, heart tissues, and blood leucocytes in modelling of cholesterol atherosclerosis. Fiziol Zh. 2007;53:3–10. [Ukrainian].
    14.  
  14. Tsymbalyuk VI, Iarmoliuk IeS. A modified model of experimental ischemic stroke in rats using silicone coating monofilaments. Ukr Nevrolog Zh. 2012; 4:97-105. [Ukrainian].
    15.  
  15. Qiu JH, Asai A, Chi S. Proteasome inhibitors induce cytochrome C-caspase-3-like protease-mediated apoptosis in cultured cortical neurons. J Neurosci. 2000; 20(1):259-70.
    16.  
  16. Hershko A, Heller H, Elias S, Ciechanover A. Components of ubiquitinprotein ligase system. Resolution, affinity purification, and role in protein breakdown. J Biol Chem. 1983; 258: 8206–14.
    17.  
  17. Ding Q, Dimayuga E, Martin S. Characterisation of chronic low-level proteasome inhibition on neural homeostasis. Neurochem. 2003;86:489-97. CrossRef  
  18. Taglialatela G, Kaufmann JA, Trevino A, Perez-Polo JR. Central nervous system DNA fragmentation induced by the inhibition of nuclear factor Brit Neuroreport. 1998; 9:489–93.
    19.  
  19. Keller JN, Huang FF, Zhu H, Yu J, Ho YS, Kindy TS. Oxidative stress-associated impairment of proteasome activity during ischemia reperfusion injury. J Cereb Blood Flow Metab. 2000;20:1467–73. CrossRef PubMed
    20.  
  20. Hensley K, Hall N, Subramaniam R, Cole P, Harris M, Aksenov M, Aksenova M, Gabbita SP, Wu JF, Carney JM, Markesbery WR, Butterfield DA. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J Neurochem. 1995; 65:2146–56. CrossRef PubMed
    21.  
  21. Cardozo C., Michaud C. Proteasome-mediated degradation of tau proteins occur independently of the chymotrypsinlike activity by a nonprocessive pathway. Arch Biochem Biophys. 2002;408(1):103-10. CrossRef  
  22. Ciechanover A. The ubiquitin-proteasome proteolytic pathway. Cell. 1994;79:13–21. CrossRef  

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2024.